Shares of Henry Schein, Inc. (NASDAQ:HSIC) have earned a consensus rating of “Hold” from the nineteen research firms that are presently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $73.80.
A number of equities analysts recently issued reports on HSIC shares. BidaskClub upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, February 7th. Leerink Swann cut Henry Schein from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $75.00 to $70.00 in a report on Wednesday. They noted that the move was a valuation call. Craig Hallum cut their target price on Henry Schein from $96.00 to $72.00 and set a “buy” rating on the stock in a report on Tuesday, February 19th. ValuEngine cut Henry Schein from a “sell” rating to a “strong sell” rating in a report on Sunday, February 10th. Finally, Royal Bank of Canada cut their target price on Henry Schein to $69.00 and set a “sector perform” rating on the stock in a report on Tuesday, February 12th.
In other news, Director Philip A. Laskawy sold 1,084 shares of the firm’s stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $59.86, for a total transaction of $64,888.24. Following the completion of the sale, the director now directly owns 32,899 shares of the company’s stock, valued at approximately $1,969,334.14. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Philip A. Laskawy sold 3,591 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $59.12, for a total value of $212,299.92. The disclosure for this sale can be found here. Corporate insiders own 1.06% of the company’s stock.
Shares of Henry Schein stock traded down $0.22 on Thursday, reaching $67.09. 814,989 shares of the company’s stock were exchanged, compared to its average volume of 1,837,319. The stock has a market capitalization of $9.98 billion, a price-to-earnings ratio of 16.24, a PEG ratio of 2.40 and a beta of 0.89. Henry Schein has a 52 week low of $56.58 and a 52 week high of $91.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.93 and a current ratio of 1.65.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04. Henry Schein had a return on equity of 18.35% and a net margin of 4.10%. The company had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.36 billion. During the same period last year, the business earned $0.95 EPS. Henry Schein’s quarterly revenue was up 3.8% compared to the same quarter last year. On average, equities research analysts forecast that Henry Schein will post 3.46 EPS for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Story: Why is a lock-up period needed for an IPO?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.